. Author manuscript; available in PMC: 2021 Sep 3.

Published in final edited form as: Eur J Haematol. 2017 Oct 8;99(6):532–535. doi: 10.1111/ejh.12970

Table 2.

Transplant outcomes

	Inpatient (%) n=669	Outpatient (%) n=377	P
Time to Engraftment, days
Platelets, 20,000	11 [5–42]	11 [7–70]	0.05
Neutrophils, ANC 500	11 [7–16]	11 [9–15]	0.05
Treatment Related Deaths: Total	22 (3)	4 (1)	0.04
Infection	8 (1.2)	1 (0.3)
Cardiac Failure	3 (0.4)	1 (0.3)
Other	11 (1.6)	2 (0.6)
Treatment Related Deaths: Day 100	10 (1.5)	1 (0.3)	0.10
Adverse Events
Grade II–IV	552 (83)	277 (73)	0.003
Grade III/IV	359 (54)	163 (44)	0.003
Grade IV	19 (3)	6 (2)	0.2
Final Response Post Auto HSCT
CR/VGPR/PR	599 (89.5)	364 (96.5)	<0.0001
<PR	42 (6.3)	7 (1.9)
PD	21 (3.2)	5 (1.3)
NE	7 (1)	1 (0.3)